Pr. Peter Carmeliet Pr. Peter Carmeliet
AXA Project in Exploration of Endothelial cell metabolism
As of today, aging and its associated progressive loss of physical integrity remains the prime risk factor in cancer development. As refined parasites, developing tumors hijack the vascular system of their hosts in order to promote their own growth.
Prof. Peter Carmeliet aims to explore this from a rather novel angle. Indeed, a large number of cancer therapies inhibit the creation of new blood vessels caused by chemicals released from tumors; however, these strategies are reaching their limits. In particular, they present serious side effects, such as toxicity and resistance incurred by patients. Carmeliet suggests reversing the process: what if, instead of starving tumors by blocking their blood stock, we starved the blood vessels themselves by cutting off their power supply?
Discover research projects related to the topic
Mécénat des Mutuelle
France
CLIMABRAIN: Impacts of Extreme Weather on the Most Vulnerable Living with Alzheimer's disease
In the context of the increase in extreme weather events due to climate change, the project led by Tarik Benmarhnia... Read more
Tarik
BENMARHNIA
Institut National de la Santé et de la Recherche Médicale
Chronic & Non-communicable Diseases
Medical Treatment & Drug Development
Chronic Pain & Musculoskeletal Disorders
Drug Delivery
Biotech- and Nanotechnology
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Chronic pain is recognized as a major public health problem affecting patients in their daily activity, physical and mental health,... Read more
Celine
GRECO